Should the sale of analgesic mixtures and non-steroidal anti-inflammatory agents (NSAIDs) continue to be allowed as over-the-counter (OTC) medications?
The excessive use of analgesics and non-steroidal antiinflammatory agents (NSAIDs) is strongly associated with an increased prevalence of chronic renal insufficiency, some cases requiring long term replacement therapy (dialysis/transplantation). Analgesic nephropathy (AN) is now a well defined entity characterized by papillary necrosis and/or chronic interstitial nephritis. The elderly are especially susceptible and more frequently use these medications. Although the overall incidence of AN is low considering the widespread usage and pain and suffering alleviated by their ready availability over-the-counter (OTC), the need, as public policy, to better protect our citizens by restricting free access to these drugs remains open to debate.
Lindeman
R D
RD
D000700:Analgesics / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D004338:Drug Combinations; D004335:Drug and Narcotic Control; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000139:chemically induced; D004366:Nonprescription Drugs / Q000009:adverse effects
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D004366:Nonprescription Drugs